{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:12:40Z","timestamp":1753891960134,"version":"3.41.2"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T00:00:00Z","timestamp":1594684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012041","name":"Versus Arthritis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012041","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2020.01051","type":"journal-article","created":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T05:00:04Z","timestamp":1594702804000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Persistence of Mast Cell-Positive Synovitis in Early Rheumatoid Arthritis Following Treatment With Conventional Synthetic Disease Modifying Anti-Rheumatic Drugs"],"prefix":"10.3389","volume":"11","author":[{"given":"Felice","family":"Rivellese","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca W.","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Giorli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filomena","family":"Napolitano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amato","family":"de Paulis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Costantino","family":"Pitzalis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,7,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1136\/ard.2010.138461","article-title":"2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"69","author":"Aletaha","year":"2010","journal-title":"Ann. Rheumatol. Dis."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2019.01459","article-title":"A combined transcriptomic and genomic analysis identifies a gene signature associated with the response to anti-TNF therapy in rheumatoid arthritis","volume":"10","author":"Aterido","year":"2019","journal-title":"Front. Immunol."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2012.00147","article-title":"Mast Cells are Important Modifiers of Autoimmune Disease: With so Much Evidence, Why is There Still Controversy","volume":"3","author":"Brown","year":"2012","journal-title":"Front. Immunol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1002\/art.1780270802","article-title":"Articular mastocytosis in rheumatoid arthritis","volume":"27","author":"Crisp","year":"1984","journal-title":"Arthritis Rheumatol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1002\/art.1780390723","article-title":"Human synovial mast cells: I. Ultrastructural in situ and in vitro immunologic characterization","volume":"39","author":"De Paulis","year":"1996","journal-title":"Arthritis Rheumatol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"R90","DOI":"10.1186\/ar4555","article-title":"Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics","volume":"16","author":"Dennis","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"B7","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.immuni.2017.02.006","article-title":"Immunopathogenesis of Rheumatoid Arthritis","volume":"46","author":"Firestein","year":"2017","journal-title":"Immunity"},{"key":"B8","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1002\/art.1780400314","article-title":"Mast cell responses in rheumatoid synovium. Association of the MCTC subset with matrix turnover and clinical progression","volume":"40","author":"Gotis-Graham","year":"1997","journal-title":"Arthritis Rheumatol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1136\/ard.57.11.664","article-title":"Synovial mast cell responses during clinical improvement in early rheumatoid arthritis","volume":"57","author":"Gotis-Graham","year":"1998","journal-title":"Ann. Rheumatol. Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1136\/ard.2004.029751","article-title":"Synovial tissue macrophages: a sensitive biomarker for response to treatment in patients with rheumatoid arthritis","volume":"64","author":"Haringman","year":"2005","journal-title":"Ann. Rheumatol. Dis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1371\/journal.pmed.0060001","article-title":"Ectopic lymphoid structures support ongoing production of class-switched autoantibodies in rheumatoid synovium","volume":"6","author":"Humby","year":"2009","journal-title":"PloS Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1136\/annrheumdis-2018-214539","article-title":"Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients","volume":"78","author":"Humby","year":"2019","journal-title":"Ann. Rheumatol. Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1136\/annrheumdis-2013-204603","article-title":"Ultrasound-guided synovial biopsy: A safe, well-tolerated and reliable technique for obtaining high-quality synovial tissue from both large and small joints in early arthritis patients","volume":"74","author":"Kelly","year":"2015","journal-title":"Ann. Rheumatol. Dis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1111\/j.1365-2559.2006.02508.x","article-title":"Synovitis score: discrimination between chronic low-grade and high-grade synovitis","volume":"49","author":"Krenn","year":"2006","journal-title":"Histopathology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2015.00620","article-title":"Mast cell: A multi-functional master cell","volume":"6","author":"Krystel-Whittemore","year":"2016","journal-title":"Front. Immunol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1126\/science.1073176","article-title":"Mast cells: a cellular link between autoantibodies and inflammatory arthritis","volume":"297","author":"Lee","year":"2002","journal-title":"Science"},{"year":"2018","key":"B17","article-title":"NICE - Rheumatoid arthritis in adults: management"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1136\/ard.2010.134528","article-title":"Collagen-induced arthritis is not impaired in mast cell-deficient mice","volume":"70","author":"Pitman","year":"2011","journal-title":"Ann. Rheumatol. Dis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1097\/BOR.0b013e32835fd8eb","article-title":"New learnings on the pathophysiology of RA from synovial biopsies","volume":"25","author":"Pitzalis","year":"2013","journal-title":"Curr. Opin. Rheumatol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13075-016-0970-9","article-title":"Immunopathologic characterization of ultrasound-defined synovitis in rheumatoid arthritis patients in clinical remission","volume":"18","author":"Ram\u00edrez","year":"2016","journal-title":"Arthritis Res. Ther."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1002\/art.39192","article-title":"Ability of Interleukin-33- and Immune Complex-Triggered Activation of Human Mast Cells to Down-Regulate Monocyte-Mediated Immune Responses","volume":"67","author":"Rivellese","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.autrev.2017.04.001","article-title":"Mast cells in rheumatoid arthritis: friends or foes","volume":"16","author":"Rivellese","year":"2017","journal-title":"Autoimmun. Rev."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1136\/annrheumdis-2018-213418","article-title":"Mast cells in early rheumatoid arthritis associate with disease severity and support B cell autoantibody production","volume":"77","author":"Rivellese","year":"2018","journal-title":"Ann. Rheumatol. Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1002\/art.41184","article-title":"B cell synovitis and clinical phenotypes in rheumatoid arthritis: relationship to disease stages and drug exposure","volume":"72","author":"Rivellese","year":"2019","journal-title":"Arthritis Rheumatol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms20082040","article-title":"Mast cells in early rheumatoid arthritis","volume":"20","author":"Rivellese","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B26","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1002\/art.38996","article-title":"Mast cell promotion of T cell-driven antigen-induced arthritis despite being dispensable for antibody-induced arthritis in which T cells are bypassed","volume":"67","author":"Schubert","year":"2015","journal-title":"Arthritis Rheumatol. (Hoboken N.J.)"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0140-6736(16)30173-8","article-title":"Rheumatoid arthritis","volume":"6736","author":"Smolen","year":"2016","journal-title":"Lancet"},{"key":"B28","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.ejphar.2015.03.085","article-title":"Mast cells in rheumatic disease","volume":"778","author":"Suurmond","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s13075-016-1036-8","article-title":"Mast cell depletion in the preclinical phase of collagen-induced arthritis reduces clinical outcome by lowering the inflammatory cytokine profile","volume":"18","author":"van der Velden","year":"2016","journal-title":"Arthritis Res. Ther."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2017.00424","article-title":"Are mast cells MASTers in cancer","volume":"8","author":"Varricchi","year":"2017","journal-title":"Front. Immunol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/imr.12627","article-title":"Human mast cells and basophils-How are they similar how are they different","volume":"282","author":"Varricchi","year":"2018","journal-title":"Immunol. Rev."},{"key":"B32","doi-asserted-by":"publisher","first-page":"115","DOI":"10.2174\/1874312901105010115","article-title":"Synovial Tissue Response to Treatment in Rheumatoid Arthritis","volume":"5","author":"Vieira-Sousa","year":"2011","journal-title":"Open Rheumatol. J."},{"key":"B33","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/nri3427","article-title":"Protective and pathological roles of mast cells and basophils","volume":"13","author":"Voehringer","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"2797","DOI":"10.1084\/jem.20071391","article-title":"Mast cell deficiency in Kit(W-sh) mice does not impair antibody-mediated arthritis","volume":"204","author":"Zhou","year":"2007","journal-title":"J. Exp. Med."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2020.01051\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T05:00:07Z","timestamp":1594702807000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2020.01051\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,14]]},"references-count":34,"alternative-id":["10.3389\/fphar.2020.01051"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2020.01051","relation":{},"ISSN":["1663-9812"],"issn-type":[{"type":"electronic","value":"1663-9812"}],"subject":[],"published":{"date-parts":[[2020,7,14]]},"article-number":"1051"}}